{"symbol": "KPTI", "companyName": "Karyopharm Therapeutics Inc.", "exchange": "Nasdaq Global Select", "industry": "Drug Manufacturers", "website": "http://www.karyopharm.com", "description": "Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class drugs directed against nuclear transport and related targets to treat cancer and other diseases.", "CEO": "Michael G. Kauffman", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Drug Manufacturers - Specialty & Generic", "Drug Manufacturers"]}